Literature DB >> 23188549

NSGC practice guideline: risk assessment and genetic counseling for hereditary breast and ovarian cancer.

Janice L Berliner1, Angela Musial Fay, Shelly A Cummings, Brittany Burnett, Todd Tillmanns.   

Abstract

PURPOSE: The purpose of this document is to present a current and comprehensive set of practice recommendations for effective genetic cancer risk assessment, counseling and testing for hereditary breast and ovarian cancer. The intended audience is genetic counselors and other health professionals who care for individuals with, or at increased risk of, hereditary breast and/or ovarian cancer.

Entities:  

Mesh：

Year:  2012        PMID： 23188549     DOI： 10.1007/s10897-012-9547-1

Source DB:  PubMed          Journal:  J Genet Couns        ISSN： 1059-7700            Impact factor:   2.537


  48 in total

Review 1.  Assessing the risk of breast cancer.

Authors:  K Armstrong; A Eisen; B Weber
Journal:  N Engl J Med       Date:  2000-02-24       Impact factor: 91.245

2.  The western Swedish BRCA1 founder mutation 3171ins5; a 3.7 cM conserved haplotype of today is a reminiscence of a 1500-year-old mutation.

Authors:  A Bergman; Z Einbeigi; U Olofsson; Z Taib; A Wallgren; P Karlsson; J Wahlström; T Martinsson; M Nordling
Journal:  Eur J Hum Genet       Date:  2001-10       Impact factor: 4.246

3.  Banning genetic discrimination.

Authors:  Henry T Greely
Journal:  N Engl J Med       Date:  2005-09-01       Impact factor: 91.245

Review 4.  Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement.

Authors: 
Journal:  Ann Intern Med       Date:  2005-09-06       Impact factor: 25.391

5.  Hereditary breast and ovarian cancer syndrome.

Authors: 
Journal:  Gynecol Oncol       Date:  2009-04       Impact factor: 5.482

6.  Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors.

Authors:  Bronson D Riley; Julie O Culver; Cécile Skrzynia; Leigha A Senter; June A Peters; Josephine W Costalas; Faith Callif-Daley; Sherry C Grumet; Katherine S Hunt; Rebecca S Nagy; Wendy C McKinnon; Nancie M Petrucelli; Robin L Bennett; Angela M Trepanier
Journal:  J Genet Couns       Date:  2011-12-02       Impact factor: 2.537

7.  Cancer Incidence in BRCA1 mutation carriers.

Authors:  Deborah Thompson; Douglas F Easton
Journal:  J Natl Cancer Inst       Date:  2002-09-18       Impact factor: 13.506

8.  Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.

Authors:  Kelly Metcalfe; Henry T Lynch; Parviz Ghadirian; Nadine Tung; Ivo Olivotto; Ellen Warner; Olufunmilayo I Olopade; Andrea Eisen; Barbara Weber; Jane McLennan; Ping Sun; William D Foulkes; Steven A Narod
Journal:  J Clin Oncol       Date:  2004-06-15       Impact factor: 44.544

9.  American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.

Authors: 
Journal:  J Clin Oncol       Date:  2003-04-11       Impact factor: 44.544

10.  Rapid progression of prostate cancer in men with a BRCA2 mutation.

Authors:  S A Narod; S Neuhausen; G Vichodez; S Armel; H T Lynch; P Ghadirian; S Cummings; O Olopade; D Stoppa-Lyonnet; F Couch; T Wagner; E Warner; W D Foulkes; H Saal; J Weitzel; A Tulman; A Poll; R Nam; P Sun; Jessica Danquah; Susan Domchek; Nadine Tung; Peter Ainsworth; Douglas Horsman; Charmaine Kim-Sing; Christine Maugard; Andrea Eisen; Mary Daly; Wendy McKinnon; Marie Wood; Claudine Isaacs; Dawna Gilchrist; Beth Karlan; Raluca Nedelcu; Wendy Meschino; Judy Garber; Barbara Pasini; Siranoush Manoukian; Christina Bellati
Journal:  Br J Cancer       Date:  2008-06-24       Impact factor: 7.640
View more
  50 in total

1.  Integrating genetic and genomic information into effective cancer care in diverse populations.

Authors:  L Fashoyin-Aje; K Sanghavi; K Bjornard; J Bodurtha
Journal:  Ann Oncol       Date:  2013-10       Impact factor: 32.976

2.  The Genetics Journey: A Case Report of a Genetic Diagnosis Made 30 Years Later.

Authors:  Linford A Williams; Shane C Quinonez; Wendy R Uhlmann
Journal:  J Genet Couns       Date:  2017-06-13       Impact factor: 2.537

3.  An investigation of genetic counselors' testing recommendations: pedigree analysis and the use of multiplex breast cancer panel testing.

Authors:  Meghan G Lundy; Andrea Forman; Kathleen Valverde; Lisa Kessler
Journal:  J Genet Couns       Date:  2014-02-27       Impact factor: 2.537

4.  Collaboration of colorado cancer genetic counselors to integrate next generation sequencing panels into clinical practice.

Authors:  K Wolfe Schneider; A Anguiano; L Axell; C Barth; K Crow; M Gilstrap; B A Hamlington; S Lesh; L Mullineaux; A Kulchak Rahm; E Strait; M Freivogel
Journal:  J Genet Couns       Date:  2014-05-01       Impact factor: 2.537

Review 5.  Genetic counseling for Fanconi anemia: crosslinking disciplines.

Authors:  Heather A Zierhut; Rebecca Tryon; Erica M Sanborn
Journal:  J Genet Couns       Date:  2014-09-20       Impact factor: 2.537

6.  A Two-Phase Approach to Developing SNAP: an iPhone Application to Support Appointment Scheduling and Management for Women with a BRCA Mutation.

Authors:  Courtney Lynam Scherr; Jessica L Feuston; Dawn M Nixon; Stephanie A Cohen
Journal:  J Genet Couns       Date:  2018-02-08       Impact factor: 2.537

7.  Breast Cancer Survivors' Knowledge of Hereditary Breast and Ovarian Cancer following Genetic Counseling: An Exploration of General and Survivor-Specific Knowledge Items.

Authors:  Courtney L Scherr; Juliette Christie; Susan T Vadaparampil
Journal:  Public Health Genomics       Date:  2015-09-22       Impact factor: 2.000

8.  Cancer Genetic Counseling and Testing in an Era of Rapid Change.

Authors:  Gillian W Hooker; Keelia Rhoads Clemens; John Quillin; Kristen J Vogel Postula; Pia Summerour; Rebecca Nagy; Adam H Buchanan
Journal:  J Genet Couns       Date:  2017-04-22       Impact factor: 2.537

9.  Evolution of Hereditary Breast Cancer Genetic Services: Are Changes Reflected in the Knowledge and Clinical Practices of Florida Providers?

Authors:  Deborah Cragun; Courtney Scherr; Lucia Camperlengo; Susan T Vadaparampil; Tuya Pal
Journal:  Genet Test Mol Biomarkers       Date:  2016-08-15

10.  Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing.

Authors:  Priyanka Sharma; Jennifer R Klemp; Bruce F Kimler; Jonathan D Mahnken; Larry J Geier; Qamar J Khan; Manana Elia; Carol S Connor; Marilee K McGinness; Joshua M W Mammen; Jamie L Wagner; Claire Ward; Lori Ranallo; Catherine J Knight; Shane R Stecklein; Roy A Jensen; Carol J Fabian; Andrew K Godwin
Journal:  Breast Cancer Res Treat       Date:  2014-05-07       Impact factor: 4.872
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.